Two Sigma Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-119,312
Closed -$445K 3518
2024
Q3
$445K Sell
119,312
-14,632
-11% -$54.6K ﹤0.01% 2461
2024
Q2
$750K Sell
133,944
-29,491
-18% -$165K ﹤0.01% 2079
2024
Q1
$856K Sell
163,435
-44,179
-21% -$231K ﹤0.01% 1988
2023
Q4
$1.09M Buy
207,614
+174,934
+535% +$915K ﹤0.01% 1951
2023
Q3
$515K Buy
32,680
+3,576
+12% +$56.4K ﹤0.01% 2192
2023
Q2
$566K Buy
+29,104
New +$566K ﹤0.01% 2208
2021
Q2
Sell
-127,206
Closed -$5.31M 2990
2021
Q1
$5.31M Buy
127,206
+21,524
+20% +$898K 0.01% 803
2020
Q4
$4.92M Buy
105,682
+53,409
+102% +$2.49M 0.01% 742
2020
Q3
$2.22M Buy
52,273
+17,509
+50% +$744K 0.01% 880
2020
Q2
$1.67M Buy
+34,764
New +$1.67M 0.01% 949
2019
Q2
Sell
-97,049
Closed -$4.9M 2505
2019
Q1
$4.9M Buy
97,049
+3,789
+4% +$191K 0.02% 818
2018
Q4
$3.76M Buy
+93,260
New +$3.76M 0.01% 826
2018
Q3
Sell
-47,901
Closed -$3.62M 2426
2018
Q2
$3.62M Buy
+47,901
New +$3.62M 0.01% 833
2017
Q1
Sell
-33,437
Closed -$2.65M 2496
2016
Q4
$2.65M Buy
+33,437
New +$2.65M 0.01% 1010
2016
Q2
Sell
-9,300
Closed -$377K 2388
2016
Q1
$377K Sell
9,300
-8,924
-49% -$362K ﹤0.01% 1698
2015
Q4
$1.62M Sell
18,224
-72,646
-80% -$6.44M 0.01% 1038
2015
Q3
$6.73M Buy
90,870
+48,544
+115% +$3.59M 0.03% 436
2015
Q2
$3.42M Sell
42,326
-4,679
-10% -$378K 0.02% 831
2015
Q1
$1.97M Buy
+47,005
New +$1.97M 0.01% 1084